Suchergebnisse - "You, Seng Chan"

PubPharm (6)

1

Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users : a nationwide retrospective cohort study

enthalten in: BMC pharmacology & toxicology | 2022

von Park, J. | You, S. | Cho, J. | +4

2

Thirty-Day Outcomes of Children and Adolescents With COVID-19 : An International Experience

enthalten in: Pediatrics | 2021

von Duarte-Salles, T. | Vizcaya, D. | Pistillo, A. | +39

UpdateOf: medRxiv. 2020 Oct 30;:. - PMID 33140074

3

Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers : A Multinational Cohort Study

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2021

von Chen, R. | Suchard, M. | Krumholz, H. | +9

CommentIn: Circulation. 2022 Feb 8;145(6):413-415. - PMID 35130055

4

Large-scale evidence generation and evaluation across a network of databases (LEGEND) : assessing validity using hypertension as a case study

enthalten in: Journal of the American Medical Informatics Association : JAMIA | 2020

von Schuemie, M. | Ryan, P. | Pratt, N. | +6

ErratumIn: J Am Med Inform Assoc. 2021 Jan 15;28(1):196. - PMID 33099616

5

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis

enthalten in: Scientific reports | 2020

von Kim, Y. | Tian, Y. | Yang, J. | +18

6

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension

enthalten in: JAMA internal medicine | 2020

von Hripcsak, G. | Suchard, M. | Shea, S. | +7

CommentIn: JAMA Intern Med. 2020 Aug 1;180(8):1133. - PMID 32568361

1
[1]